Versatile qualitative PCR detection
The system employs short chain primers and a neural network to analyze genetic material fingerprints, addressing the limitations of current PCR methods by enabling efficient identification of multiple genetic sources, including unknown pathogens, with high throughput and accuracy.
Patent Information
- Application Number
- PCT/CA2026/050699
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-16
- Filing Date
- 2026-05-15
- Publication Date
- 2026-11-19
AI Technical Summary
Current PCR methods are limited to identifying a single genetic sample to an already sequenced source, making them impractical for samples containing unidentified or un-sequenced genetic materials, and developing a library of every genetic sequence would be time-consuming and costly.
A system using short chain primers, fluorophores, and a neural network to analyze genetic material fingerprints, allowing scalable and efficient identification of multiple genetic materials without sequencing, and a method to train the neural network using a dataset of known sources.
Enables rapid identification of multiple genetic sources, including unknown pathogens, with high throughput and accuracy, refining the neural network through positive identifications and unknown pathogen detection.
Smart Images

Figure CA2026050699_19112026_PF_FP_ABST
Abstract
Description
Docket No. G10119162P1PCTVERSATILE QUALITATIVE PCR DETECTIONCROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority under 35 U.S.C. § 119(e) and 37 C.F.R. § 1.78 to provisional application no. 63 / 806,913 filed on May 16, 2025, titled “VERSATILE QUALITATIVE PCR DETECTION" which is hereby incorporated by reference herein in its entirety.BACKGROUND
[0002] There are several pathogens, which include bacteria, viruses, parasites and fungi, known to affect humans, with many more emerging. Many of these pathogens have yet to be identified. Quick and easy detection of pathogens is needed for both private and public health reasons. However, as many pathogens are yet to be discovered and many commonly exist together, forming biodiverse environments in many areas, including the people's bodies, soil, and even the atmosphere, detection of pathogens can be time consuming and provide inaccurate results.BRIEF SUMMARY
[0003] In one embodiment, a system for identifying the source of at least one genetic material is disclosed. The system includes a plurality of wells to receive the at least one genetic material, a short chain primer and a fluorophore coupled to the short chain primer positioned within each of the plurality of wells, a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells, a sensor to measure a signal emitted from each of the plurality of wells after amplification, a network, and a processor and a database in communication with the sensor via the network.
[0004] Optionally, in some embodiments, the short chain primer is 8 nucleotides or less.
[0005] Optionally, in some embodiments, the short chain primer is 5 nucleotides.
[0006] Optionally, in some embodiments, each of the plurality of wells contains at least two different short chain primers.
[0007] Optionally, in some embodiments, the signal is light emitted from each of the plurality of wells.
[0008] Optionally, in some embodiments, the thermocycler is a qPCR thermocycler configured to have high throughput.Docket No. G10119162P1PCT
[0009] Optionally, in some embodiments, the fluorophore includes one or more of FAM, HEX, and Cy5.
[0010] Optionally, in some embodiments, the system includes at least one nucleic acid aptamer to chelate with a toxin.
[0011] In another embodiment, a method for identifying at least one source of genetic material is disclosed. The method includes collecting a sample with the at least one source of genetic material, extracting at least one genetic material from the sample, using qPCR to generate a fingerprint from the at least one genetic material using a plurality of short chain primers, sensing the fingerprint, and identifying the at least one source of genetic material using a neural network.
[0012] Optionally, in some embodiments, the method includes short chain primers are 6 nucleotides or less in length.
[0013] Optionally, in some embodiments, the at least one source of genetic material is an unknown source of genetic material and / or a new source of genetic material.
[0014] Optionally, in some embodiments, the method includes an ultrafast qPCR device used to generate the fingerprint.
[0015] Optionally, in some embodiments, the method includes silica spin columns and / or magnetic bead extraction to extract the genetic material from the sample.
[0016] Optionally, in some embodiments, the method includes adding at least one nucleic acid aptamer to the sample to chelate with at least one toxin in the sample.
[0017] Optionally, in some embodiments, the method includes a photodiode to sense the fingerprint generated by qPCR.
[0018] Optionally, in some embodiments, the method includes loading a first well with a first combination of the plurality of short chain primers, loading a second well with a second combination of the plurality of short chain primers, loading a third well with a third combination of the plurality of short chain primers, and loading a fourth well with a fourth combination of the plurality of short chain primers, wherein each of the second combination, the third combination, and the fourth combination are mutually exclusive from one another and are a subset of the first combination of the plurality of short chain primers.
[0019] In another embodiment, a method of training a neural network is disclosed. The method includes creating a dataset of at least one of a fingerprint corresponding to a known source of genetic material, feeding the dataset into a neural network model, adjusting a weight of the neural network model to fine-tune an output of the neural network model, andDocket No. G10119162P1PCT repeating adjusting the weight of the neural network model until an error level reaches a threshold value.
[0020] Optionally, in some embodiments, the fingerprint includes a plurality of signals produced from a plurality of short chain primers annealing and amplifying to at least one nucleic acid sequence.
[0021] Optionally, in some embodiments, the method includes short chain primers 6 nucleotides or less.
[0022] Optionally, in some embodiments, the method includes a neural network model that includes at least one specialized model to identify a group of nucleic acid sequences.
[0023] Optionally, in some embodiments, the method includes an additional neural network model trained to process an output of the at least one specialized model.
[0024] In another embodiment, a system for identifying the source of at least one genetic material is disclosed. The system includes a plurality of wells configured to receive respective portions of the at least one genetic material, a short chain primer and a first tail sequence coupled at a 5' end of the short chain primer within at least one well of the plurality of wells, a probe comprising a probe sequence, a fluorophore coupled to a 5' end of the probe sequence, a second tail sequence coupled at a 3' end of the probe sequence, and a quencher coupled to the 3' end of the probe sequence, wherein in a first configuration, the quencher is adjacent to the fluorophore, and in a second configuration, the quencher is positioned away from the fluorophore, a thermocycler configured to receive the plurality of wells and to amplify the at least one genetic material, a sensor to measure a signal emitted from each of the plurality of wells after amplification, a network, and a processor and a database in communication with the sensor via the network.
[0025] Optionally, in some embodiments, the first tail sequence and the second tail sequence include the same arrangement of nucleotides.
[0026] Optionally, in some embodiments, the second tail sequence is coupled to the probe at a 5' end of the probe sequence, and the fluorophore is coupled to the probe sequence.
[0027] Optionally, in some embodiments, the probe sequence is arranged in a hairpin configuration.
[0028] Optionally, in some embodiments, the short chain primer comprises 8 nucleotides or less.
[0029] In one embodiment, a system for identifying the source of at least one genetic material is disclosed. The system includes a plurality of wells to receive the at least one genetic material, a short chain primer and a first tail sequence coupled at a 5' end of theDocket No. G10119162P1PCT short chain primer within at least one of the plurality of wells, a probe comprising a probe sequence, a fluorophore coupled to a 5' end of the probe sequence, and a quencher coupled to a 3' end of the probe sequence, wherein in a first configuration the quencher is adjacent to the fluorophore and in a second configuration the fluorophore is decoupled from the probe sequence, a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells, a sensor to measure a signal emitted from each of the plurality of wells after amplification, a network, and a processor and a database in communication with the sensor via the network.
[0030] In one embodiment, a method for identifying at least one source of genetic material is disclosed. The method includes extracting at least one genetic material from a sample, generating a first qPCR fingerprint using a general primer set, sensing, by a photo sensor, the first qPCR fingerprint, analyzing the first qPCR fingerprint by a neural network, generating a second qPCR fingerprint using a primer subset determined by the analysis of the first qPCR fingerprint, sensing the second qPCR fingerprint, and analyzing the second qPCR fingerprint by the neural network.
[0031] In another embodiment, a system for identifying the source of at least one genetic material is disclosed. The system includes a plurality of wells to receive the at least one genetic material, a short chain primer and a degenerate sequence coupled at a 5' end of the short chain primer within at least one of the plurality of wells, a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells, a sensor to measure a signal emitted from each of the plurality of wells after amplification, a network in communication with the sensor, a processor in communication with the sensor via the network, and a database in communication with the sensor and the processor via the network.
[0032] In one embodiment, a system for identifying the source of at least one genetic material is disclosed. The system includes a plurality of wells to receive the at least one genetic material, a short chain primer and a tail sequence coupled at a 5' end of the short chain primer within at least one of the plurality of wells, a probe comprising a second tail sequence, a probe sequence, and a fluorophore, wherein in a first configuration, the probe is coupled to the tail sequence and in a second configuration, the probe is decoupled from the tail sequence, a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells, a sensor to measure a signal emitted from each of the plurality of wells after amplification, a network, and a processor and a database in communication with the sensor via the network.Docket No. G10119162P1PCT BRIEF DESCRIPTION OF THE DRAWINGS
[0033] FIG. 1 is a simplified schematic view of an example system.
[0034] FIG. 2 is a flowchart of an example method to identify sources of genetic material.
[0035] FIG. 3 is a flowchart of a method to use qPCR data to train a neural network.
[0036] FIG. 4 is a flowchart of another example of a method in FIG. 2 to identify sources of genetic material.
[0037] FIG. 5 A is an example embodiment of a portion of the system in FIG. 1 in one configuration used to generate a qPCR fingerprint disclosed herein.
[0038] FIG. 5B is another example embodiment of the system in FIG. 5 A in a different configuration used to generate a qPCR fingerprint disclosed herein.
[0039] FIG. 6A is an example embodiment of a portion of the system in FIG. 1 in one configuration used to generate a qPCR fingerprint disclosed herein.
[0040] FIG. 6B is an example embodiment of the system in FIG. 6A in a different configuration used to generate a qPCR fingerprint disclosed herein.
[0041] FIG. 7 A is an example embodiment of a portion of the system in FIG. 1 in one configuration used to generate a qPCR fingerprint disclosed herein.
[0042] FIG. 7B is an example embodiment of the system in FIG. 7 A in a different configuration used to generate a qPCR fingerprint disclosed herein.
[0043] FIG. 8 is a flow chart of an example method to load qPCR wells to identify sources of genetic material suitable for use with any system disclosed herein.
[0044] FIG. 9 is a flow chart of an example method to identify sources of genetic material suitable for use with any system disclosed herein.
[0045] FIG. 10 is another example embodiment of the system of FIG. 1 configured to generate a qPCR fingerprint disclosed herein.DETAILED DESCRIPTION
[0046] Many fields today, including medical diagnostics, forensic analysis, genetic research, and environmental monitoring, benefit from genetic identification. Genetic identification typically uses the polymerase chain reaction (PCR) to amplify (i.e., generate copies of) genetic material, also known as nucleic acid sequences, so the genetic material may be accurately analyzed and the source of the genetic material can be identified. Current PCR methods are limited to identifying a single genetic sample to an already sequenced source. However, many real-world samples do not contain a single source of geneticDocket No. G10119162P1PCT material. Samples may also contain unidentified or un-sequenced genetic materials, making the application of current PCR techniques impractical for identification, as every source of genetic material would already need to be identified and sequenced. However, developing a library of every genetic sequence would be extremely time consuming and costly. Even if such a library existed, current PCR methods could not be performed at the scale necessary to use the library. The following disclosure includes various methods and systems capable of scalable and efficient identification of the sources of a sample with various genetic materials using unique primer lengths and qualitative PCR (qPCR).
[0047] As one example, the system includes a thermocycler, a sensor, a processor with a memory bank, and a network. A sample is prepared to extract the genetic material. Portions of the genetic material are then placed in several wells, each well with different short chain primers tagged with fluorophores. As used herein, a short chain primer is a DNA sequence with eighteen or fewer nucleotides. For example, a short chain primer may have 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18 nucleotides. In some embodiments, the number of nucleotides may be selected based on the scale of genomes and the uniqueness of nucleotide sequences. For example, the short chain primer may include 11 nucleotides for bacterial scale genomes because an 11 nucleotide sequence may appear at least once in a bacterial scale genome. The thermocycler amplifies the genetic material responsive to the primers, and the sensor detects light emitted by fluorophores from each well, creating a unique fingerprint without the need to sequence the genetic material. A processor and network then use a neural network to analyze the fingerprint and identify the sources of the genetic materials.
[0048] For example, the system may rapidly identify pathogens for use in medical diagnostics. A person possibly affected by pathogens may provide a sample. After processing to purify and extract genetic material(s) from the sample, qPCR analysis then creates a fingerprint from the light emitted by tags attached to different short length primers. A sensor detects the different light emitted from the different tags, creating the fingerprint. A neural network then analyzes the fingerprint and identifies the pathogens contained within the sample. After the one or more pathogens are detected, the appropriate remedy may be applied to the affected person(s).
[0049] In order to identify the sources of genetic material, the neural network must be trained. The neural network is trained on a dataset built by analyzing the fingerprints of samples with already known sources of genetic material. Subsequent fingerprints with positive identifications are fed to a cloud database to rapidly train and refine the neural network. The neural network can then analyze the fingerprint from new samples andDocket No. G10119162P1PCT identify the sources of genetic material in the sample, including samples with a mix of genetic material sources.
[0050] The system can also detect the presence of unknown pathogens, which can be classified and used to refine the neural network. For example, a sample may contain a mix of known and unknown pathogens. The system produces a fingerprint via qPCR of the sample. The neural network is able to analyze the fingerprint to identify the known pathogens and detect the presence of unknown pathogens. The sample may be taken to a lab to sequence the unknown pathogens and / or assign a strain ID for each unknown pathogen. The fingerprint of each positive detection of the unknown pathogens would be added to the dataset, training the neural network, until the system is confidently able to identify the pathogen without confirmation from a lab.
[0051] Turning to the figures, FIG. 1 shows a simplified schematic view of an embodiment of a system 100, including a plurality of wells 102, a short chain primer 104, a fluorophore 106, a thermocycler 108, a sensor 110, a network 112, and a processor and memory 114. As shown for example in FIG. 1, some embodiments of the system 100 include a user interface 116.
[0052] Genetic materials are received by the plurality of wells 102 to facilitate qPCR. At least one of the short chain primers 104 is positioned within each of the plurality of wells 102. Each of the short chain primers 104 is tagged with fluorophore 106.
[0053] The system 100 may work with any thermocycler to amplify the genetic material, including traditional PCR thermocyclers, and / or qPCR thermocyclers, either of which may be configured for high throughput. For example, a high-throughput thermocycler may include at least two zones, and may include a third or more zones (e.g., a first zone, a second zone, or a third zone). The high-throughput thermocycler also includes a vessel, such as a needle or other relatively thin container. The vessel may be configured to hold a sample. The high-throughput thermocycler also includes an actuator configured to introduce movement to the vessel. The vessel may be a thin-walled (e.g., the wall thickness may range from approximately 0.10 mm to 0.35 mm) cylindrical element like a needle. In some embodiments, the sample volume may be in the inclusive range of about 0.5 to 50 pL. In some embodiments, a sample may occupy only a portion of the inner volume of the needle and thus may be smaller than this range (e.g., the volume may be less than 0.5 pL). The small sample volume, thin wall, and high surface area (relative to the sample volume) enable the rapid change of temperature of the samples. For example, temperature change rates of up to 2000 °C per second or more are achievable with the high-throughputDocket No. G10119162P1PCT biological assay system. One such example is described in U.S. Provisional No. 63 / 708,099 titled High Throughput Biological Assay Systems and Methods filed on October 16, 2024, and incorporated by reference herein in its entirety.
[0054] The thermocycler 108 is configured to receive the plurality of wells 102. For example, the thermocycler 108 may receive 96 wells. The thermocycler 108 may receive more or fewer wells, depending on the desired fingerprint. The thermocycler 108 may cycle through different temperatures to amplify genetic material. For example, the thermocycler 108 may set the temperature of the plurality of wells 102 to denature genetic material (e.g., 95 °C). Genetic material is denatured as the hydrogen bonds coupling the complementary nucleotide of the genetic material are broken, resulting in two single strands of genetic material. The thermocycler 108 may then set the temperature of the plurality of wells 102 so that the primers (e.g., the short chain primer 104) may anneal to the denatured genetic material (e.g., from 50 - 60) by forming hydrogen bonds with the complementary nucleotides of the denatured genetic material. A 3’ end of primers (e.g., the short chain primer 104) is a terminal end of the nucleotide sequence with a free hydroxyl group, which allows enzymes (e.g., DNA polymerase, RNA polymerase, or Taq polymerase) to add nucleotides to the primer, amplifying the genetic material. A 5' end of the primer (e.g., the short chain primer 104) is a terminal end opposite of the 3’ end, and generally includes a free phosphate group.
[0055] After the thermocycler 108 completes a number of cycles, the sensor 110 detects the light emitted by the fluorophore 106. The fluorophore 106 attached to each of the short chain primers 104 may differ. For example, in a well with three different short chain primer 104, FAM, HEX, and Cy5 fluorophores may be used.
[0056] As used herein FAM is a fluorescent reporter dye comprising a fluorescein derivative capable of emitting detectable fluorescence upon excitation at a characteristic wavelength. The dye exhibits an excitation maximum of approximately 490-495 nm and an emission maximum of approximately 520-525 nm, producing a green fluorescence signal. FAM may be operably linked to an oligonucleotide, including a probe or primer, to enable detection of nucleic acid amplification products in real-time PCR or related fluorescencebased assays.
[0057] As used herein HEX is a fluorescent dye derived from a chlorinated fluorescein scaffold, wherein substitution with halogen atoms results in a red-shifted emission spectrum relative to fluorescein-based dyes. HEX is characterized by an excitation maximum of approximately 530-535 nm and an emission maximum of approximately 550-560 nm,Docket No. G10119162P1PCT producing a yellow-green fluorescence signal. The dye may be conjugated to nucleic acid probes or primers to facilitate detection and differentiation of amplification products, particularly in multiplex PCR assays.
[0058] As used herein Cy5 is a member of the cyanine class of fluorescent dyes, comprising a polymethine bridge linking heterocyclic moieties to produce a far-red fluorescent reporter. Cy5 exhibits an excitation maximum of approximately 640-650 nm and an emission maximum of approximately 660-670 nm, generating a red fluorescence signal. The dye may be covalently attached to oligonucleotides, including probes and primers, to enable sensitive detection of nucleic acid targets, particularly in multiplex amplification reactions where spectral separation from shorter-wavelength fluorophores is desired.
[0059] The sensor 110 may be a photo sensor, such as a photodiode that can perform fluorescence detection, and / or a luminescence detector capable of detecting the different intensity and / or wavelength of light emitted from each well. The sensor 110 may be coupled to the thermocycler 108, for example, wired together. In some embodiments, the sensor 110 may be in wireless communication with the thermocycler 108 via the network 112.
[0060] The sensor 110 sends information to the processor and memory 114 to be analyzed by a neural network. As shown in FIG. 1, the processor and memory 114 may be in communication with the sensor 110 via the network 112. In some embodiments, the network 112 may be a local network. For example, the sensor 110 and the processor and memory 114 may be in communication via hard wiring, or via a local wireless network. In some embodiments, the sensor 110 is in wireless communication with the processor and memory 114. In some embodiments, the sensor 110 may be in optical communication with the processor and memory 114. In some embodiments, the sensor 110 may be in electronic communication with the processor and memory 114.
[0061] Some embodiments of the system 100 include the user interface 116. The user interface 116 allows a user to control the system and interpret the identification results. The user interface 116 may include a computer system to allow the user to interact with the system 100. The user interface 116 may also allow a user to train neural networks, as described herein.
[0062] With reference to FIG. 2 and FIG. 4, the system 100 may be used to execute methods to identify the source of genetic material. For example, a method 200, as shown in FIG. 2, identifies the source of genetic material beginning with operation 202 to collect a sample with at least one source of genetic material. The sample may come from anyDocket No. G10119162P1PCT environment with pathogens, such as bodies of liquids, soils, body fluids, etc., and may be collected via swabbing.
[0063] The method 200 then proceeds to operation 204 to extract the genetic material from the sample so that the genetic material can properly amplify in the plurality of wells 102. The genetic material may be extracted by first lysing the sample to release the genetic material and denature the helix structure to prepare it for amplification (i.e., the process to produce copies of the genetic material). For example, the sample may be heated to 95 °C for two minutes to lyse the sample. After lysing, the genetic material is separated and removed from other components that may inhibit the amplification of the genetic material. For example, after lysing, the proteins, fats, and carbohydrates may be removed from the sample. In some embodiments, biological inhibitors may be added to help facilitate the separation and removal of proteins, fats, and carbohydrates. In some embodiments, silica spin columns are used to filter the sample. In some embodiments, magnetic bead extraction may be used in combination with filtration, or as a standalone process, to remove proteins, fats and carbohydrates. In some embodiments, long chain nucleic acid sequences, such as human chromosome DNA, are removed as well.
[0064] After extracting the genetic material, the method 200 may proceed to operation 206 to generate a fingerprint from the genetic material using short chain primers, e.g., the short chain primers 104. The fingerprint is a compilation of signals represented as a plurality of tokens. In some embodiments, the signals are light signals. For example, light emitted from a fluorophore may be used as a signal. To generate a fingerprint, the system 100 is configured to receive and analyze a plurality of wells, where the genetic material is placed in. The thermocycler 108 receives the wells and amplifies the genetic material for a set number of cycles, such as, for example, 40 cycles. Each well contains different short chain primers 104 and fluorophores 106. Each primer and fluorophore combination creates a token the system 100 analyzes. For example, the genetic material may be placed in at least 96 wells, each with three different short chain primers, each primer in the well with an attached fluorophore, resulting in at least 288 tokens. In some embodiments, one or more types of fluorophores may be used in a system, such as the system 100. For example, a single well of the plurality of wells 102 may include a first short chain primer, a second short chain primer, and a third short chain primer. The first short chain primer may be tagged with FAM, the second short chain primer may be tagged with HEX, and the third short chain primer may be tagged with Cy5. In another example, a single type of fluorophore may be used to tag all short chain primers in the plurality of wells 102.Docket No. G10119162P1PCT
[0065] The short chain primers 104 provide the fingerprint more specificity than longer primers due to a higher number of bonding sites to genetic materials. For example, the system 100 may use 5 nucleotide primers, although shorter and longer primers may also be used, e.g., 4 nucleotide primers, 6 nucleotide primers, 7 nucleotide primers, or 8 nucleotide primers may be used. The short chain primers 104 also allow the system 100 to identify several sources of genetic material at any given time. For example, short chain primers may bond / anneal to substantially all genetic sequences, allowing the short chain primers 104 to be used to identify substantially all genetic sequences. The short chain primers 104 are chosen so they bond to different sequences at different rates. For example, a primer set may bond with the nucleic acid sequence of Ebola a different number of times than the nucleic acid sequence of covid during a cycle. In some embodiments, cosine similarity may be used to determine the combination of primers in each well. The short chain primer 104 length may also affect the number of different primers in each of the plurality of wells 102. In some embodiments, the short chain primers 104 may be chosen to tailor the system 100 to identify a particular group of genetic materials. For example, a particular set of the short chain primers 104 may be selected if the system 100 is used to identify human gut microbiota.
[0066] The fluoro phore 106 produces the signal detected by the system 100. The fluorophore detaches from the short chain primer 104 if the short chain primer 104 begins amplification of a nucleic acid sequence. When the fluorophore 106 detaches, light is emitted via fluorescence creating a detectable signal. Different fluorophores 106 may fluoresce different colors. For example, a well may contain three different short chain primers 104 with three different fluorophores 106 attached, as shown for example in FIG. 4. If all three short chain primers 104 amplify a portion of a nucleic acid sequence, three different colors of light will be emitted. Thus, each token may have a corresponding color, i.e., signal, corresponding to a particular combination of the short chain primer 104 and the fluorophore 106. Since multiple tokens may come from the same well, each well may create a unique signal corresponding to a primer set. In some embodiments, the intensity of the light emitted may be used to determine the amount of short chain primer 104 used to amplify the nucleic acid sequence. As shown for example in FIG. 4, tokens may produce signals from a mix of genetic materials, which may convolve into a single signal.
[0067] The system 100 may proceed to sense the fingerprint and identify the sources of genetic material in operation 208. First, the signals of the fingerprint are detected by sensor 110. For example, the sensor 110 may detect the color / wavelength and / or intensity of the light emitted in each well. In some embodiments, the sensor 110 may detect signals duringDocket No. G10119162P1PCT each cycle the thermocycler 108 performs. In some embodiments, the sensor 110 may detect signals only after the thermocycler 108 performs all cycles. Data of the signal is then sent to the processor and memory 114 via the network 112. The processor and memory 114 then analyze the signal data with a neural network. The neural network determines how much of each short chain primer 104 in each of the plurality of wells 102 is used to amplify genetic material from the signal data. Furthermore, the neural network parses out the signal produced by each different genetic material in the sample by deconvoluting the convolved signal, as shown for example in FIG. 4. By analyzing and comparing the deconvoluted signals to a training set library, the neural network interprets the data and identifies the sources of genetic material contained in the sample.
[0068] Unlike current PCR identification techniques, some embodiments of the methods executed by system 100 may also detect unknown sources of genetic materials. If the neural network cannot match a fingerprint of deconvoluted signals to the training set library, then the neural network may classify the identity of the genetic material as a potentially new source of genetic material, as shown for example in FIG. 4.
[0069] In some embodiments, the system 100 may identify toxins, as well as sources of genetic materials. Although toxins do not contain genetic material, nucleic acid aptamers may chelate to toxins. The nucleic acid aptamers may then undergo qPCR, allowing the system 100 to execute methods similar to the method 200 to identify toxins contained within the sample.
[0070] FIG. 3 is a flowchart of example method 300 to train the neural network to identify sources of genetic material. The method 300 may begin with operation 302, to create a dataset of fingerprints corresponding to known sources of genetic material, then proceed to operation 304, which feeds the dataset into a neural network model. To optimize the accuracy of the model, the method may adjust a weight to fine-tune an output of the neural network model in operation 306. In operation 308, iterations of operation 306 allow an error value of the neural network model to reach a threshold value, signaling the neural network model has reached an accuracy ready for deployment.
[0071] In order to create the dataset of fingerprints in operation 302, samples with known sources of genetic materials may be fingerprinted. For example, a sample known to only include a strain of the covid virus may be fingerprinted. The dataset may include a fingerprint of a single nucleic acid sequence, and / or a fingerprint of a sample with multiple different nucleic acid sequences. For example, a sample known to only include three different strains of the covid virus may be fingerprinted.Docket No. G10119162P1PCT
[0072] In operation 304, the neural network model processes the dataset. In some embodiments, the dataset may compile smaller sub datasets of fingerprints directed towards a particular group of nucleic acid sequences. For example, a sub dataset may include fingerprints for samples containing different strains of the covid virus. In some embodiments, the neural network model includes at least one smaller neural network model and one larger neural network model. These smaller neural network models may process a sub dataset, allowing the smaller neural network to train more efficiently and produce more accurate outputs than a large comprehensive model for a particular group of nucleic acid sequences. The at least one smaller neural network model may feed outputs into the larger neural network model, which processes the outputs of the smaller neural network models and provides an output that identifies the sources of all the nucleic acid sequences contained in the sample.
[0073] In operation 306, the neural network model is fine-tuned by adjusting at least one weight of the neural network model. For example, the neural network may process a sample and provide an output indicating the identity of the genetic materials in the sample. A lab may also process the sample to confirm the identities through traditional identification methods. Based on the lab results, the output of the neural network may be adjusted by changing a parameter, or a weight, of the model. In some embodiments, several weights may be adjusted. Once the weight is adjusted, the neural network may provide a more accurate subsequent identification.
[0074] In operation 308, operation 306 is repeated until an error level reaches a threshold value. The error level measures the inaccuracy of the neural network model output. The number of iterations depends on the threshold value. More iterations may be required to fine-tune the neural network model to produce accurate results.
[0075] FIG. 4 illustrates an example embodiment of the method 200 of FIG. 2. As shown in FIG. 4, the method 200 may begin by collecting a sample 402. The sample 402 may include pathogens 404.
[0076] The method 200 may proceed to the operation 204 to extract genetic material from the sample. As shown in FIG. 4, sample genetic material 408 (e.g., DNA and / or RNA) may be extracted from the pathogens 404 within the sample 402.
[0077] The method 200 may then proceed to the operation 206 to generate a qPCR fingerprint using short chain primers. The operation 206 may begin by placing the sample genetic material 408 in a plurality of wells, e.g., a well 406. The plurality of wells are loaded with enzymes and short chain primers (e.g., enzymes 410 and unique primer triplexDocket No. G10119162P1PCT 412) as described in a legend 414. The three different primers (shown as PRIMER 1, PRIMER 2, and PRIMER 3) of the unique primer triplex 412 are distinguished illustratively by different hatchings, as shown in a legend 416. As shown for example in FIG. 4, the primers of the unique primer triplex 412 may anneal to sample genetic material 408 during qPCR operations. During qPCR operations, a thermocycler (e.g., the thermocycler 108 as described herein) may cycle through selected temperatures (e.g., from 90 to 100, from 45 to 70, and / or from 70 to 75). During qPCR operations, the unique short chain primers 412 may anneal to the denatured sample genetic material 408, and the enzymes 410 may replicate the short chain primers 412, amplifying the sample genetic material 408 and generating a qPCR fingerprint 418 as described herein.
[0078] As shown for example in FIG. 4, the enzymes 410 may be lyophilized. Lyophilized enzymes improve storage qualities, such as shelf life, storage temperature, etc., compared to non-lyophilized enzymes. The enzymes 410 facilitate DNA and / or RNA amplification, such as by the polymerase chain reaction, and are thermostable during qPCR operations (e.g., the enzymes do not denature at temperature up to 100 °C, such as up to 99 °C, up to 98 °C, up to 97 °C, up to 96 °C, up to 95 °C, and / or up to 94 °C. For example, the enzymes may include, but are not limited to, one or more of Taq polymerase, Tfl polymerase, Pfu polymerase, Deep Vent polymerase, Q5 polymerase, or reverse transcriptase.
[0079] As used herein Taq polymerase is a thermostable (at typical PCR reaction temperatures) DNA-dependent DNA polymerase derived from the thermophilic bacterium Thermus ciquciticus . The enzyme is capable of catalyzing the template-directed synthesis of DNA at elevated temperatures, with optimal activity at approximately 72 °C. Taq polymerase lacks intrinsic 3'— >5' exonuclease proofreading activity, and therefore exhibits a relatively higher error rate during DNA synthesis compared to proofreading enzymes.
[0080] As used herein TH polymerase is a thermostable DNA polymerase isolated from Thermus flavus. Like Taq polymerase, TH polymerase is capable of mediating DNA synthesis under elevated temperature conditions typical of PCR processes, with an optimal activity range of approximately 72-75 °C. Tfl polymerase lacks 3'— >5' exonuclease proofreading activity and therefore exhibits a fidelity profile comparable to or modestly improved relative to Taq polymerase. The enzyme may be used in nucleic acid amplification reactions, particularly where variations in enzyme kinetics or buffer compatibility are desired.
[0081] As used herein Pfu polymerase is a thermostable DNA polymerase obtained from the hyperthermophilic archaeon Pyrococcus fur iosus. The enzyme is characterized by theDocket No. G10119162P1PCT presence of intrinsic 3'— >5' exonuclease proofreading activity, which confers significantly enhanced fidelity during DNA synthesis relative to non-proofreading polymerases. Pfu polymerase is capable of catalyzing DNA strand elongation at elevated temperatures, typically with optimal activity around 72 °C. Due to its high accuracy, the enzyme is particularly suitable for applications requiring precise DNA amplification, including cloning, mutagenesis, and sequencing.
[0082] As used herein Deep Vent polymerase is a thermostable (at typical PCR temperatures) DNA polymerase derived from Thermococcus litoralis, an organism isolated from deep-sea hydrothermal vent environments. The enzyme exhibits both polymerase activity and intrinsic 3'— >5' exonuclease proofreading capability, resulting in high-fidelity DNA synthesis compared to some other enzymes. Deep Vent polymerase is stable under extreme thermal conditions (e.g., ~95 °C during PCR denaturation steps) and maintains enzymatic activity at temperatures typically used in PCR amplification (-50-65 °C (primer annealing), -72 °C (DNA extension)). The combination of thermal stability and proofreading activity renders the enzyme suitable for amplification of complex or GC-rich templates (high proportion of guanine (G) and cytosine (C) bases) and for applications requiring increased accuracy.
[0083] As used herein Q5 polymerase is an engineered, high-fidelity DNA polymerase comprising a modified archaeal polymerase backbone with enhanced properties, including increased fidelity, processivity, and robustness. The enzyme possesses 3'— >5' exonuclease proofreading activity and demonstrates a substantially reduced error rate relative to conventional polymerases. Q5 polymerase is optimized for high-performance PCR applications and is capable of efficient DNA amplification across a broad range of template types, including those with high GC content or secondary structure. The enzyme typically exhibits optimal activity at approximately 72 °C and is particularly suited for applications requiring ultra-high accuracy, such as next-generation sequencing library preparation and precision cloning. A triplex of 5 nucleotide primers may be used to execute a method to identify a source of a genetic material, such as the method 200.
[0084] After the qPCR fingerprint 418 (shown illustratively as a box) is generated, the method may proceed to the operation 208 to sense the qPCR fingerprint and identify the source of the sample genetic material 408, the pathogen 404, using a neural network. The operation 208 senses each of the signals for each of the unique primer triplex 412 used in a well (e.g., a well 420). The neural network may then analyze the signals in the qPCR fingerprint 418 to match an existing qPCR fingerprint in the qPCR fingerprint library 422 to the qPCR fingerprint 418. The neural network may cross reference the qPCR fingerprint 418Docket No. G10119162P1PCT with a qPCR fingerprint library 422, which includes a plurality of validated qPCR fingerprints, such as a qPCR fingerprint 424. In some embodiments, the qPCR fingerprint may match with multiple qPCR fingerprints from the qPCR fingerprint library 422, indicating multiple pathogens as the source of the sample genetic material 408. For example, as shown in FIG. 4, the neural network may identify a qPCR fingerprint 426, a qPCR fingerprint 428, and a qPCR fingerprint 430 matches the signals provided in the qPCR fingerprint 418. In some embodiments, unknown qPCR fingerprints are added back into the qPCR fingerprint library. For example, as shown in FIG. 4, the qPCR fingerprint 430 is added to the qPCR fingerprint library 422, illustrated by the arrow and dotted box inside the qPCR fingerprint library 422. It is appreciated that the description of the foregoing embodiment in FIG. 4 is provided for purposes of illustration and description and is not intended to be exhaustive or to limit the invention to the precise forms described. Modifications and variations are contemplated within the scope of the disclosure.
[0085] With reference to FIGS. 5A-7B, systems (e.g., the system 100) may use additional embodiments of short chain primers (e.g., a short chain primer 502 and / or a short chain primer 602) and probes (e.g., a probe 504 and / or a probe 604) in lieu of or in combination with the fluorophore 106 and the short chain primer 104. The short chain primers and the probes may be used to emit light as described in more detail herein. The light may be sensed and captured by a sensor (e.g., a photo sensor as described herein) to generate a qPCR fingerprint, such as the qPCR fingerprints generated in the method 200 and the method 300.
[0086] FIGS. 5 A - 5B illustrate one such embodiment of short chain primers and probes, system 500. System 500 includes a short chain primer 502, a tail sequence 508a, and a probe 504.
[0087] Similar to the short chain primer 104, the short chain primer 502 may anneal to genetic material during the qPCR operations. The tail sequence 508a is a non-complementary sequence of nucleotides coupled to the 5' end of the short chain primer 502. The tail sequence 508a does not bind to denatured genetic material during a first cycle, but becomes incorporated into the amplicons of genetic material as qPCR operations proceeds through more than one cycle to generate copies of the genetic material (amplification). The tail sequence 508a is attached to the short chain primer 502 on a 5' end 506 of the short chain primer, as a 3' end 510 controls the specificity of the amplification during qPCR operations. The arrangement of nucleotides of the tail sequence 508a may be selected to provide suitable selectivity during amplification. For example, the tail sequence 508a may be selected to reduce mispriming and / or dimer formation. Mispriming describes when a primer anneals to an unintended non-compl ementary sequence, and / or partially anneals toDocket No. G10119162P1PCT complementary sequence, which may lead to the amplification of an unintended sequence. Dimer formation describes when primers may anneal to themselves or to another primer instead of the target genetic material (e.g., the sample genetic material 408). The number of nucleotides may also be selected to provide suitable selectivity for annealing to sampled genetic material. For example, the tail sequence may be from 1 - 5 nucleotides long, or from 3 - 15 nucleotides long, or from 5 - 25 nucleotides long. Since mismatched nucleotide pairs destabilize genetic material, longer sequences reduce the likelihood the tail sequence 508a and / or the tail sequence 508b will anneal to the incorrect sequence, providing more specificity than the use of shorter nucleotide sequences.
[0088] The probe 504 is a sequence of nucleotides selected to bind to complementary portions of genetic material downstream in a 3' direction from the short chain primer 502. The probe 504 includes a tail sequence 508b, a probe sequence 512, a fluorophore 514, and a quencher 520. The tail sequence 508b is a sequence of nucleotides attached to a 3’ end of the probe sequence 512. The fluorophore 514 is similar to the fluorophore 106 but is coupled to the probe 504 instead of the short chain primer 502. The fluorophore 514 is coupled to a 5’ end of the probe sequence 512. The quencher 520 is a molecule that absorbs or dissipates light emitted by fluorophores (e.g., the fluorophore 514). For example, the quencher may be an organic compound, such as 4-(4-dimethylaminophenylazo)benzoic acid (DABCYL), tetramethylrhodamine, and / or black hole quenchers (e.g., BHQ-1, BHQ-2, etc.). The quencher 520 is coupled to the 3’ end of the probe sequence 512.
[0089] The probe 504 may selectively configure to prevent or allow the fluorophore 514 to emit a signal. For example, as shown in FIG. 5A, in a first configuration, the quencher 520 may position adjacent to the fluorophore 514 before the extension of additional nucleotides of the short chain primer 502 engages with the probe 504. Since the quencher 520 is adjacent to the fluorophore 514, the quencher 520 may absorb a light emitted by the fluorophore 514. In a second configuration, as shown in FIG. 5B, the quencher 520 is no longer adjacent to the fluorophore 514 (e.g., is positioned away from the fluorophore 514), and a signal 528, such as light, (shown illustratively as an arrow in FIG. 5B) by the fluorophore 514 is no longer absorbed by the quencher 520, and may be detected by a detector 530 (e.g., a photo sensor) to generate a qPCR fingerprint.
[0090] During qPCR operations (e.g., the operation 206), the short chain primer 502 is extended with additional nucleotides by an enzyme (e.g., polymerase may extend the nucleotide sequence of the short chain primer 502) to generate copies, or amplify, genetic material during an initial cycle. In subsequent cycles, the tail sequence 508a becomes incorporated into the amplicons, and complementary sequences to the tail sequence 508aDocket No. G10119162P1PCT may be amplified. The tail sequence 508b may bind to the sequences complementary to the tail sequence 508a. The enzyme may then extend the tail sequence 508b (e.g., polymerase may extend the nucleotide sequence of the tail sequence 508b). The enzyme may engage with the probe sequence 512 to change the configuration of the probe 504 from the first configuration to the second configuration, allowing the fluorophore 514 to emit the signal 528 (e.g., light emissions). The signal 528 may then be sensed or detected. For example, as shown in FIG. 5B, the detector 530 may detect the signal 528. In some embodiments, the enzyme change the position of the quencher 520 by cleaving a portion of hydrogen bonds of the probe 504. In other embodiments, the extension may cleave the probe 504 to free the fluorophore 514. The configuration of the probe 504 may allow the fluorophore 514 to emit the signal 528 in selective manner, as the probe 504 only changes configuration if the tail sequence 508b binds to complementary genetic material. Thus, the fluorophore 514 only emits the signal 528 when the probe sequence 512 and the tail sequence 508b, both of which may be selected based on a desired interaction with sample genetic material, successfully bind to complementary genetic material. For example, the probe sequence 512 and the tail sequence 508b may include a longer sequence of nucleotides than the short chain primer 502, and the fluorophore 514 will only emit light once a complementary sequence of nucleotides of the probe sequence 512 and the tail sequence 508b is formed and bound to. Thus, the probe 504 may provide a qPCR fingerprint with a more selective signal resolution than fingerprints generated using only fluorophores coupled to the short chain primers without the use of probes. Examples of probe 504 and their corresponding sequences are described herein as shown in Table 1._ Zfluorophore / probe sequence / quencher / tail sequence _ / 5-FAM / AGCGATGCGTTCGAGCATCGC / iBHQ-dT / GAAGGTGACCAAGTTCATGCT / 5HEX / AGGACGCTGAGATGCGTCC / iBHQ-ldT / GAAGGTCGGAGTCAACGGATT / 5Cy5 / AGTTACCGGTTCGACGGTAAC / iBHQ-2dT / GAAGGTTCACAACATTTCCAG Table 1: Examples of Probe 504
[0091] In some embodiments, the probe sequence 512 is configured in a hairpin, as shown illustratively for example in FIGS. 5A -5B. The hairpin is an arrangement of nucleotides of the probe sequence 512 with portions of the terminal end portions of the annealed to each other (e.g., forming a stem section), shown as a terminal portion 522 and a terminal portion 524. In some embodiments, as shown in FIG. 5A, a middle portion of the nucleotide sequence remains un-annealed (e.g., forming a loop section) and is selected to anneal to the target complementary genetic material. In a first configuration, as shown in FIG. 5A, the hairpin arrangement positions the quencher 520 adjacent to the fluorophore 514. DuringDocket No. G10119162P1PCT qPCR operations, the extension of the tail sequence 508b may engage the hairpin arrangement by separating the terminal portion 522 and the terminal portion 524 of the hairpin arrangement of the probe sequence 512. For example, as shown in FIG. 5B, in a second configuration, the terminal portion 524 extends away from the terminal portion 522, and the quencher 520 is no longer positioned adjacent to the fluorophore 514 (e.g., is positioned away from the fluorophore 514), allowing the signal 528 emitted by the fluorophore 514 to be captured by the detector 530.
[0092] In some embodiments, the probe 504 may be coupled to the short chain primer 502 (e.g., a scorpion PCR probe). For example, the short chain primer 502 may be covalently linked to the probe 504 on the 3’ end in a single intramolecular construct. In a first configuration, the probe 504 may include a probe sequence 512 configured in as a hairpin as described herein. During qPCR operations, such as during amplification, the short chain primer 504 is extended with nucleotides by an enzyme (e.g., polymerase). After denaturation and annealing, the probe 504 may fold back to the newly synthesized target strand, opening the hairpin configuration of the probe sequence 512 (e.g., the probe 504 changes to a second configuration), decoupling the fluorophore 514 and the quencher 520, allowing the fluorophore to emit a signal (e.g., the light 528) captured by the detector 530.
[0093] The system 500 may be used with any suitable qPCR systems disclosed herein, such as the system 100 and the system 600 (described in more detail herein). For example, the system 500 may be used in combination with the system 100 and / or the system 600. The system 500 may also be used to execute suitable methods for genetic material identification, such as the method 200, and / or methods to train neural networks to identify genetic material, such as the method 300, and / or the method 800 and the method 900, described in detail herein.
[0094] In some embodiments, the system 500 may be used to in combination with methods using multiple short chain primers. For example, the method 200 may use three different (a triplex) of short chain primers (e.g., short chain primers 502) in each of the plurality of wells. Each of the short chain primers may be coupled to a tail sequence (e.g., tail sequences 508a). Each of the tail sequences may include a different nucleotide sequence from each other. The probes (e.g., probes 504) will include the corresponding tail sequences.
[0095] FIGS. 6 A - 6B show another illustrative embodiment of short chain primers and probes that may be used during qPCR, a system 600. The system 600 includes a short chain primer 602, a tail sequence 608a, and a probe 604. The probe 604 includes a probe sequence 612, a fluorophore 614, and a quencher 620.Docket No. G10119162P1PCT
[0096] Similar to the system 500, the system 600 may allow the fluorophore 614 to selectively emit a light 624. The short chain primer 602, the tail sequence 608a, the probe sequence 612, the fluorophore 612, and the quencher 620 operate similarly to the short chain primer 502, the tail sequence 508a, the probe sequence 512, the fluorophore 512, and the quencher 520 as described herein.
[0097] The system 600 differs from the system 500 in that the fluorophore 614 is decoupled from the probe 604 if the probe sequence 612 is annealed during qPCR operations. For example, as shown in FIG. 6A, in a first configuration, the fluorophore 614 is coupled to the probe 604 and positioned adjacent to the quencher 620 (e.g., the quencher 620 may be positioned adjacent and downstream in a 3’ direction from the fluorophore 614). By being adjacent to the fluorophore 614, the quencher prevents (e.g., by absorbing) a signal 624 (e.g., light) from being received by a detector 622. During qPCR operations, operation 206 for example, the short chain primer 602 may anneal to the genetic material within a sample (e.g., RNA or DNA captured in a sample for testing) during amplification. The probe sequence 612 may also anneal to the genetic material downstream of the short chain primer 602 in a 3' direction during qPCR operations (e.g., operation 206). During qPCR operations (e.g., operation 206) an enzyme (e.g., polymerase) may extend the short chain primer 602 by coupling additional nucleotides to the 3' end 610 of the short chain primer 602. Once the enzyme reaches the probe sequence 612, the enzyme may decouple (e.g., by cleaving the hydrogen bonds annealing the probe sequence 612 to the genetic material) the fluorophore 614 from the probe 604, changing the configuration of the probe 604 from the first configuration to a second configuration. In the second configuration of the probe 604 (shown for example in FIG. 6B), the fluorophore 614 is decoupled from the probe 604 and the signal 624, such as light, (illustrated as an arrow in FIG. 6B) emitted from the fluorophore 614 may be captured by the detector 622. In some embodiments, the quencher 620 may be cleaved from the probe 604.
[0098] The system 600 may be used with suitable qPCR systems, such as the system 100 and the system 500. For example, the system 600 may be used in combination with the system 100 and / or the system 600. The system 600 may also be used to execute suitable methods for genetic material identification, such as the method 200, and / or methods to train neural networks to identify genetic material, such as the method 300, and / or the method 800 and the method 900, described in detail herein.
[0099] FIGS. 7A - 7B show another illustrative embodiment of short chain primers and probes that may be used during qPCR, a system 700. The system 700 includes a short chain primer 702, a tail sequence 704 coupled to a 5' end 720 of the short chain primer 702, and aDocket No. G10119162P1PCT probe 716. The probe 716 includes a probe sequence 706, a fluorophore 708, and a quencher 710.
[0100] Similar to the system 500, the system 700 may allow the fluorophore 708 to emit a signal 714, such as light. The short chain primer 702, the tail sequence 704, the fluorophore 708, and the quencher 710 operate similarly to the short chain primer 502, the tail sequence 508a, the fluorophore 514, and the quencher 520 as described herein.
[0101] The system 700 differs from the system 500 in that in a first configuration, as shown for example in the FIG. 7 A, the probe sequence 706 is annealed to the tail sequence 704 of the short chain primer 702. The system 700 also differs from the system 500 in that the system 700 includes a reverse short chain primer 718. During qPCR operations, such as operation 206 for example, the short chain primer 702 may anneal to sample genetic material (e.g., the sample genetic material 408) and an enzyme (e.g., DNA polymerase) may extend the short chain primer 702 by coupling additional nucleotides to a 3' end 722 of the short chain primer 702. In subsequent cycles during qPCR operations (e.g., the operation 206) the reverse short chain primer 718 is configured to anneal to the extended nucleotide sequence of the short chain primer 702. The enzyme may then extend the reverse short chain primer 718 by adding additional nucleotides to the sequence. As the extension of nucleotides reaches the tail sequence 704, the enzyme cleaves the probe 716, changing the probe 716 from the first configuration to a second configuration, to continue extending the reverse short chain primer 718 with additional nucleotides. In the second configuration, as shown for example in FIG. 7B, the fluorophore 708 and the quencher 710 are decoupled from the probe sequence 706 and the quencher 710 no longer prevents a detector 712 from receiving a signal 714 (e.g., light) emitted from the fluorophore 708.
[0102] The configurations of the probe 716 in the system 700 may use fewer nucleotides than other probe configurations, such as hairpin probes (e.g., the probe 504). For example, the probe sequence 706 may include fewer than 35 nucleotides, whereas the probe sequence configured as a hairpin may include 40 nucleotides or more. In some examples, the probe sequence 706 may include 25 or fewer nucleotides. The use of fewer nucleotides than may be advantageous. For example, the shorter nucleotide count of the probe sequence 706 may reduce mispriming and / or dimer formation. Fluorophores may emit a signal due to mispriming and / or dimer formation, introducing noise into a qPCR fingerprint. Therefore, in suitable embodiments, the system 700 may be advantageous to use by improving the signal resolution of the qPCR fingerprint by reducing mispriming and / or dimer formation when compared to using probes with 40 or more nucleotides (e.g., hairpin probes).Docket No. G10119162P1PCT
[0103] The system 700 may be used with suitable qPCR systems, such as the system 100 and the system 500, the system 600, and the system 1000 disclosed herein. For example, the system 700 may be used in combination with the system 100 and / or the system 600. The system 700 may also be used to execute suitable methods for genetic material identification, such as the method 200, and / or methods to train neural networks to identify genetic material, such as the method 300, and / or the method 800 and the method 900, described in detail herein.
[0104] In some embodiments, combinations of the short chain primers may be included in multiple wells to improve signal resolution by providing more signal granularity compared to using a single well with a single set of short chain primers. For example, rather than using short chain primer triplex in a single well, combinations of the short chain primer triplex may be used in multiple wells to provide more information on the short chain primer triplex. Multiple wells with multiple combinations of the same short chain primers (e.g., the short chain primer 104, the short chain primer 502, and / or the short chain primer 602), may provide better signal resolution during and / or after executing qPCR operations, such as during the operation 206 of the method 200. The number of wells may be selected depending on the number of combinations of short chain primers used to provide a desirable signal resolution when generating qPCR fingerprints. In some embodiments, the number of wells used may be at least the number of different combinations possible using at least one fewer short chain primer, and at least one additional well to include all of the set of the short chain primers. For example, if three different short chain primers (e.g., a short chain primer triplex) are included in the set, four wells may be used during qPCR operations. The additional well may include all of the short chain primers in the set.
[0105] FIG. 8 shows an example method, a method 800, of using combinations of a set of short chain primers in multiple wells. The method 800 is suitable to use with any of the systems disclosed herein. For example, the method 800 may be used with the system 100. The method 800 may also be used with short chain primers in combination with a probe (e.g., the short chain primers 502, the short chain primers 602, the probes 504 and / or the probes 604) to provide signals (e.g., the light 528 and / or the light 624) to generate qPCR fingerprints (e.g., the system 500 and / or the system 600 may be used).
[0106] Although the example method 800 depicts a particular sequence of operations, the sequence may be altered without departing from the scope of the present disclosure. For example, some of the operations depicted may be performed in parallel or in a different sequence that does not materially affect the function of the method 800. In other examples, different components of an example device or system that implements the method 800 mayDocket No. G10119162P1PCT perform functions at substantially the same time or in a specific sequence. The method 800 may be executed in combination with methods of identifying genetic material, such as the method 200, or in combination with methods of training neural networks to identify genetic material, such as the method 300.
[0107] According to some examples, the method 800 includes loading a first well with a first combination primers at operation 802. For example, if three short chain primers provide signals to generate a qPCR fingerprint, the first well may include three short chain primers. The first well may produce a first signal from the use of all three short chain primers. For example, each of the short chain primers may produce a signal as described herein. The first signal may be comprised of each individual signal produced by each of the three short chain primers. In some embodiments, this may produce a first color. For example, each of the three short chain primers may be coupled to a different fluorophore from the fluorophores coupled to the other short chain primers. A first fluorophore may couple to a first short chain primer, a second fluorophore may couple to a second short chain primer, and a third fluorophore may couple to a third short chain primer. Each fluorophore may emit a different color of light from each other, which when combined form additional colors. The use of three different fluorophores may generate the first color.
[0108] According to some examples, the method 800 includes loading a second well with a second combination of primers at operation 804. For example, the second well may include a combination of two of the three short chain primers included in the operation 802. The second well may produce a second signal from the use of the second combination of short chain primers. The second signal includes the individual signals produced by each of the two short chain primers in the second combination. In some embodiments, this may produce a second color. For example, the second combination of short chain primers may include the first fluorophore coupled to the first short chain primer, and the second fluorophore coupled to the second short chain primer. The second combination of short chain primers may produce a second color different from the first color due to the absence of the third fluorophore coupled to the third short chain primer.
[0109] According to some examples, the method 800 includes loading a third well with a third combination of primers at operation 806. For example, the third well may include a combination of two of the short chain primers included in the operation 802 different from the combination used in the operation 804. The third well may produce a third signal from the use of the third combination of short chain primers. The third signal includes the individual signals produced by each of the two short chain primers in the third combination. In some embodiments, this may produce a third color. For example, the third combination ofDocket No. G10119162P1PCT short chain primers may include the first fluorophore coupled to the first short chain primer, and the third fluorophore coupled to the third short chain primer. The third combination of short chain primers may produce a third color different from the first color and the second color due to the absence of the second fluorophore coupled to the second short chain primer.
[0110] According to some examples, the method 800 includes loading a fourth well with a fourth combination of primers at operation 808. For example, the third well may include a combination of two of the short chain primers included in the operation 802 different from the combination used in the operation 804 and the operation 806. The fourth well may produce a fourth signal from the use of the fourth combination of short chain primers. The fourth signal includes the individual signals produced by each of the two short chain primers in the fourth combination. In some embodiments, this may produce a fourth color. For example, the fourth combination of short chain primers may include the second fluorophore coupled to the second short chain primer, and the third fluorophore coupled to the third short chain primer. The fourth combination of short chain primers may produce a fourth color different from the first color, the second color, and the third color due to the absence of the first fluorophore coupled to the first short chain primer.
[0111] According to some examples, the method 800 may continue until an Nth well is loaded with an Nth combination of primers, shown for example as operation 810. In some embodiments, N not only equal to the number of groups, but the number of primers plus one.
[0112] Some sources of genetic material may be very similar to one another. For example, virus variants may include DNA or RNA that is nearly identical but with some genetic variation (e.g., the delta and omicron strains of the coronavirus (SARS-CoV-2)). In some embodiments, methods of the present disclosure may distinguish between the variants by analyzing a qPCR fingerprint of the sampled genetic material with a subset of qPCR fingerprints associated with the source of genetic material. For example, variants of the SARS-CoV-2 virus may be analyzed with a subset of qPCR fingerprints of SARS-CoV-2 variants. The methods may also provide information regarding the variation. For example, the methods may provide information regarding the amount of variation, or how quickly the genetics of the source are mutating, in addition to the identity of the one or more sources of genetic material. In some embodiments, the amount of variation may be determined by the difference between the signal measured by the variant method compared to the signal measured in the qPCR library. For example, light emitted by fluorophores may be sensed and quantified when generating a qPCR fingerprint. The quantified light measurement for each of the plurality of wells (e.g., the plurality of wells 102) for the confirmed variant’sDocket No. G10119162P1PCT qPCR fingerprint may be compared to the quantified light measurement for each of the plurality of wells of the qPCR fingerprint in the qPCR library. The difference in measurements may indicate the amount of variation, as the difference in light emitted may correlate to the number of nucleotides of the variant that is different from the sequence that generated the qPCR fingerprint in the library.
[0113] FIG. 9 illustrates an example method, a method 900, for identifying sources of genetic material, including variants. The method 900 is suitable to use with the systems disclosed herein. For example, the method 900 may be executed by the system 100. The method 900 may also be executed with the system 500 and / or the system 600, either or both of which may be executed in combination or in lieu of the fluorophore 106 and the short chain primer 104 of the system 100.
[0114] Although the example routine depicts a particular sequence of operations, the sequence may be altered without departing from the scope of the present disclosure. For example, some of the operations depicted may be performed in parallel or in a different sequence that does not materially affect the function of the routine. In other examples, different components of an example device or system that implements the routine may perform functions at substantially the same time or in a specific sequence.
[0115] Generally, a first analysis is conducted to determine a generic group of the genetic material source. For example, the genus of the source may be established. To begin such analysis, methods, like the method 900, include extracting genetic material from sample at operation 902. The operation 902 may be substantially similar to the operation 204 of the method 200.
[0116] After the genetic material is extracted, some embodiments proceed to generate and analyze a qPCR fingerprint, such as at an operation 904 of the method 900. The operation 904 may include executing qPCR operations with a general primer set. The general primer set may include selected combinations of different short chain primers that, when used to generate a qPCR fingerprint analyzed by a neural network, may provide signals to a wide variety of genetic sources. In some embodiments, the operation 904 may include analyzing the qPCR fingerprint against a general library. A general library may be a database including compiled qPCR fingerprints of known sources of genetic materials using the general primer set. Analyzing the generated fingerprint on the general primer set may not be able to distinguish among variants. For example, the operation 904 may identify the source of genetic material as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but may not be able to identify which variant of the SARS-CoV-2 virus is the source of theDocket No. G10119162P1PCT analyzed genetic material or how much of the sources of genetic material comes from each variant of the SARS-CoV-2 virus.
[0117] To identify the variant of the source of genetic material, methods of the present disclosure include generating a qPCR fingerprint using a primer subset such as at an operation 906 of the method 900. The primer subset may include a select combination of short chain primers that, when used to generate qPCR fingerprints, generate signals that may distinguish and identify the sources of genetic material, including variants. In some embodiments, the operation 906 may include analyzing the qPCR fingerprint against a subset library. The subset library may be a compilation of qPCR fingerprints generated using the primer subset. For example, the primer subset may be selected to distinguish among SARS-CoV-2 variants, and the subset library may be a compilation of qPCR fingerprints generated using the SARS-CoV-2 primer subset. In some embodiments, the general library of qPCR fingerprints may include the subset library of qPCR fingerprints.
[0118] In some embodiments, degenerate sequences attached to short chain primers may be used during qPCR operations. FIG. 10 shows an example system, a system 1000. The system 1000 comprises a short chain primer 1002 and a degenerate sequence 1004. The system 1000 may be used with the methods disclosed herein. For example, the system 1000 may be used with the method 200, the method 300, the method 800, and / or the method 900. The system 1000 is an embodiment of short chain primers that may be used in combination with, or in lieu of the system 500, the system 600, and / or the fluorophore 106 and short chain primer 104 of the system 100.
[0119] Degenerate sequences 1004 include non-specific sequences of nucleotides. Nonspecific sequences are a mixture of similar sequences that include non-specific nucleotides, designed to anneal to a different genetic sequences (e.g., the sequence of the sampled genetic material 408). For example, the degenerate sequences 1004 coupled to the short chain primers 1002 may include seven nucleotides. Six of the nucleotides may be specific, i.e., they are selected to only bind to a specific complementary genetic sequence. One of the nucleotides may be non-specific. For example, the non-specific nucleotide of the degenerate sequence 1004 may be one of adenine, cytosine, guanine, thymine, or uracil. Therefore, the degenerate sequence 1004 may bind to sequences that include the complementary sequence of the six specific nucleotides and any other nucleotide in the non-specific nucleotide position, increasing the number of matching sequences, and thereby the probability of successful amplification. The short chain primer 1002, also known as a consensus sequence, includes a sequence of specific selected nucleotides and is positioned on the 3' end of the degenerate sequence 1004, leaving a 3' end 1008 open for amplification. The resultingDocket No. G10119162P1PCT sequence of the coupled degenerate sequence 1004 and the short chain primer 1002 is longer than the short chain primer 1002 alone, allowing nucleotide sequences of complementary genetic material samples longer than the number of nucleotide sequences of the short chain primer 1002 alone to be bound to, resulting in improved amplification efficiency compared to the short chain primers alone, but maintaining the specificity of the short chain primers and providing the same meaningful information. Using degenerate sequences may improve qPCR resolution for identifying genomes of varying sizes (e.g., bacterial genomes e.g., having about 0.5-10 million base pairs vs viral genomes having about 5,000-300,000 base pairs) compared to using short chain primers without degenerate sequences.
[0120] In some embodiments, the degenerate sequence 1004 may be a selected number of nucleotides. For example, the degenerate sequence may be 1 - 5 nucleotides long, 3-10 nucleotides long, or 5-20 nucleotides long, or at least 20 nucleotides long. In one example, the degenerate sequence may be 7 nucleotides long, and the short chain primer may be 5 nucleotides long, creating a 12 nucleotide sequence. In some embodiments, short chain primers may be attached to degenerate sequences of different lengths. For example, a 5 nucleotide short chain primer may be attached to a degenerate sequence of 7 nucleotides, and another short chain primer may be attached to a degenerate sequence of 10 nucleotides. In some embodiments, the degenerate sequence may be selected to further improve selectivity and resolution. For example, the degenerate sequence may be selected to avoid dimer formation during qPCR operations, such as the operation 206 of the method 200.
[0121] The system 1000 may be used with suitable qPCR systems, such as the system 100. The system 600 may also be used to execute suitable methods for genetic material identification, such as the method 200, the method 800, the method 900, and / or methods to train neural networks to identify genetic material, such as the method 300.
[0122] The description of certain embodiments included herein is merely exemplary in nature and is in no way intended to limit the scope of the disclosure or its applications or uses. In the included detailed description of embodiments of the present systems and methods, reference is made to the accompanying drawings which form a part hereof, and which are shown by way of illustration specific to embodiments in which the described systems and methods may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice presently disclosed systems and methods, and it is to be understood that other embodiments may be utilized, and that structural and logical changes may be made without departing from the spirit and scope of the disclosure. Moreover, for the purpose of clarity, detailed descriptions of certain features will not be discussed when they would be apparent to those with skill in the art so as not to obscure theDocket No. G10119162P1PCT description of embodiments of the disclosure. The included detailed description is therefore not to be taken in a limiting sense, and the scope of the disclosure is defined only by the appended claims.
[0123] From the foregoing it will be appreciated that, although specific embodiments of the invention have been described herein for purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention.
[0124] The particulars shown herein are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present disclosure and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of various embodiments of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for the fundamental understanding of the invention, the description taken with the drawings and / or examples making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.
[0125] As used herein and unless otherwise indicated, the terms “a” and “an” are taken to mean “one”, “at least one” or “one or more”. Unless otherwise required by context, singular terms used herein shall include pluralities and plural terms shall include the singular.
[0126] Unless the context clearly requires otherwise, throughout the description and the claims, the words ‘comprise’, ‘comprising’, and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to”. Words using the singular or plural number also include the plural and singular number, respectively. Additionally, the words “herein,” “above,” and “below” and words of similar import, when used in this application, shall refer to this application as a whole and not to any particular portions of the application.
[0127] All relative, directional, and ordinal references (including top, bottom, side, front, rear, first, second, third, and so forth) are given by way of example to aid the reader’s understanding of the examples described herein. They should not be read to be requirements or limitations, particularly as to the position, orientation, or use unless specifically set forth in the claims. Connection references (e.g., attached, coupled, connected, joined, and the like) are to be construed broadly and may include intermediate members between a connection of elements and relative movement between elements. As such, connection references do not necessarily infer that two elements are directly connected and in fixed relation to each other, unless specifically set forth in the claims.Docket No. G10119162P1PCT
[0128] Of course, it is to be appreciated that any one of the examples, embodiments or processes described herein may be combined with one or more other examples, embodiments and / or processes or be separated and / or performed amongst separate devices or device portions in accordance with the present systems, devices and methods.
[0129] Finally, the above discussion is intended to be merely illustrative of the present system and should not be construed as limiting the appended claims to any particular embodiment or group of embodiments. Thus, while the present system has been described in particular detail with reference to exemplary embodiments, it should also be appreciated that numerous modifications and alternative embodiments may be devised by those having ordinary skill in the art without departing from the broader and intended spirit and scope of the present system as set forth in the claims that follow. Accordingly, the specification and drawings are to be regarded in an illustrative manner and are not intended to limit the scope of the appended claims.
Claims
Docket No. G10119162P1PCT CLAIMSWhat is claimed is:
1. A system for identifying the source of at least one genetic material, the system comprising:a plurality of wells to receive the at least one genetic material;a short chain primer and a fluorophore coupled to the short chain primer positioned within each of the plurality of wells;a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells;a sensor to measure a signal emitted from each of the plurality of wells after amplification;a network; anda processor and a database in communication with the sensor via the network.
2. The system of claim 1, wherein the short chain primer comprises 8 nucleotides or less.
3. The system of claim 1, wherein the short chain primer comprises 5 nucleotides.
4. The system of claim 1, wherein each of the plurality of wells contains at least two different short chain primers.
5. The system of claim 1, wherein the signal is light emitted from each of the plurality of wells.
6. The system of claim 1, wherein the thermocycler is a qPCR thermocycler configured to have high throughput.
7. The system of claim 1, wherein the fluorophore includes one or more of FAM, HEX, and Cy5.
8. The system of claim 1, further comprising at least one nucleic acid aptamer to chelate with a toxin.
9. A method for identifying at least one source of genetic material, the method comprising:collecting a sample with the at least one source of genetic material;extracting at least one genetic material from the sample;Docket No. G10119162P1PCT using qPCR to generate a fingerprint from the at least one genetic material using a plurality of short chain primers;sensing the fingerprint; andidentifying the at least one source of genetic material using a neural network.
10. The method of claim 9, wherein the short chain primers are 8 nucleotides or less in length.
11. The method of claim 9, wherein the at least one source of genetic material is an unknown source of genetic material and / or a new source of genetic material.
12. The method of claim 9, wherein an ultrafast qPCR device is used to generate the fingerprint.
13. The method of claim 9, wherein silica spin columns and / or magnetic bead extraction is used to extract the genetic material from the sample.
14. The method of claim 9, further comprising adding at least one nucleic acid aptamer to the sample to chelate with at least one toxin in the sample.
15. The method of claim 9, wherein a photodiode senses the fingerprint generated by qPCR.
16. The method of claim 9, further comprising loading a first well with a first combination of the plurality of short chain primers, loading a second well with a second combination of the plurality of short chain primers, loading a third well with a third combination of the plurality of short chain primers, and loading a fourth well with a fourth combination of the plurality of short chain primers, wherein each of the second combination, the third combination, and the fourth combination are mutually exclusive from one another and are a subset of the first combination of the plurality of short chain primers..
17. A method of training a neural network, the method comprising:creating a dataset of at least one of a fingerprint corresponding to a known source of genetic material;feeding the dataset into a neural network model;adjusting a weight of the neural network model to fine-tune an output of the neural network model; andrepeating adjusting the weight of the neural network model until an error level reaches a threshold value.Docket No. G10119162P1PCT 18. The method of claim 17, wherein the fingerprint comprises:a plurality of signals produced from a plurality of short chain primers annealing and amplifying to at least one nucleic acid sequence.
19. The method of claim 18, wherein the short chain primers include 6 nucleotides or less.
20. The method of claim 17, wherein the neural network model comprises at least one specialized model to identify a group of nucleic acid sequences.
21. The method of claim 20, wherein an additional neural network model is trained to process an output of the at least one specialized model.
22. A system for identifying the source of at least one genetic material, the system comprising:a plurality of wells configured to receive respective portions of the at least one genetic material;a short chain primer and a first tail sequence coupled at a 5' end of the short chain primer within at least one well of the plurality of wells;a probe comprising a probe sequence, a fluorophore coupled to a 5' end of the probe sequence, a second tail sequence coupled at a 3' end of the probe sequence, and a quencher coupled to the 3' end of the probe sequence,wherein in a first configuration, the quencher is adjacent to the fluorophore, andin a second configuration, the quencher is positioned away from the fluorophore;a thermocycler configured to receive the plurality of wells and to amplify the at least one genetic material;a sensor to measure a signal emitted from each of the plurality of wells after amplification;a network; anda processor and a database in communication with the sensor via the network.
23. The system of claim 22, wherein the first tail sequence and the second tail sequence include the same arrangement of nucleotides.
24. The system of claim 22, wherein the second tail sequence is coupled to the probe at a 5' end of the probe sequence, and the fluorophore is coupled to the probe sequence.Docket No. G10119162P1PCT 25. The system of claim 22, wherein the probe sequence is arranged in a hairpin configuration.
26. The system of claim 22, wherein the short chain primer comprises 8 nucleotides or less.
27. A system for identifying the source of at least one genetic material, the system comprising:a plurality of wells to receive the at least one genetic material;a short chain primer and a first tail sequence coupled at a 5' end of the short chain primer within at least one of the plurality of wells;a probe comprising a probe sequence, a fluorophore coupled to a 5' end of the probe sequence, and a quencher coupled to a 3' end of the probe sequence,wherein in a first configuration the quencher is adjacent to the fluorophore and in a second configuration the fluorophore is decoupled from the probe sequence; a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells;a sensor to measure a signal emitted from each of the plurality of wells after amplification;a network; anda processor and a database in communication with the sensor via the network.
28. A method for identifying at least one source of genetic material, the method comprising:extracting at least one genetic material from a sample;generating a first qPCR fingerprint using a general primer set;sensing, by a photo sensor, the first qPCR fingerprint;analyzing the first qPCR fingerprint by a neural network;generate a second qPCR fingerprint using a primer subset determined by the analysis of the first qPCR fingerprint;sensing the second qPCR fingerprint; andanalyzing the second qPCR fingerprint by the neural network.
29. A system for identifying the source of at least one genetic material, the system comprising:a plurality of wells configured to receive respective portions of the at least one genetic material;Docket No. G10119162P1PCT a short chain primer and a degenerate sequence coupled at a 5' end of the short chain primer within at least one of the plurality of wells;a thermocycler configured to amplify the at least one genetic material and configured to receive the plurality of wells;a sensor configured to measure a signal emitted from each of the plurality of wells after amplification;a network in communication with the sensor;a processor in communication with the sensor via the network; anda database in communication with the processor and the sensor via the network30. A system for identifying the source of at least one genetic material, the system comprising:a plurality of wells to receive the at least one genetic material;a short chain primer and a tail sequence coupled at a 5' end of the short chain primer within at least one of the plurality of wells;a probe comprising a second tail sequence, a probe sequence, and a fluorophore, wherein in a first configuration, the probe is coupled to the tail sequence and in a second configuration, the probe is decoupled from the tail sequence;a thermocycler to amplify the at least one genetic material and configured to receive the plurality of wells;a sensor to measure a signal emitted from each of the plurality of wells after amplification;a network; anda processor and a database in communication with the sensor via the network.
